Real-world efficacy and safety of fruquintinib plus PD-1 inhibitors with or without radiotherapy in refractory metastatic colorectal cancer: a single-center retrospective cohort study.
- DOI
- 10.21037/jgo-2026-0430
- Published
- 2026 Aug 31
- Container
- Journal of gastrointestinal oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/jgo-2026-0430,
title = {Real-world efficacy and safety of fruquintinib plus PD-1 inhibitors with or without radiotherapy in refractory metastatic colorectal cancer: a single-center retrospective cohort study.},
author = {Yi A and He L and Liu X and He Z and Liu J and Li B and Zhang H and Liu Y and Jiang C},
year = {2026},
journal = {Journal of gastrointestinal oncology},
doi = {10.21037/jgo-2026-0430},
url = {https://doi.org/10.21037/jgo-2026-0430}
}RIS
TY - JOUR TI - Real-world efficacy and safety of fruquintinib plus PD-1 inhibitors with or without radiotherapy in refractory metastatic colorectal cancer: a single-center retrospective cohort study. AU - Yi A AU - He L AU - Liu X AU - He Z AU - Liu J AU - Li B AU - Zhang H AU - Liu Y AU - Jiang C PY - 2026 JO - Journal of gastrointestinal oncology DO - 10.21037/jgo-2026-0430 UR - https://doi.org/10.21037/jgo-2026-0430 ER -
APA
A, Y., L, H., X, L., Z, H., J, L., B, L., H, Z., Y, L., & C, J. (2026). Real-world efficacy and safety of fruquintinib plus PD-1 inhibitors with or without radiotherapy in refractory metastatic colorectal cancer: a single-center retrospective cohort study.. Journal of gastrointestinal oncology. https://doi.org/10.21037/jgo-2026-0430
Source records
- pubmed · retrieved 2026-09-26T19:16:32.591Z